1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Propanc Biopharma Inc (QB) (PPCB)
  7. Quote

PPCB PPCB

Propanc Biopharma (QB) Stock Price

0.02
0.00 (0.0%)
0.02
Volume 0.00
Bid Price 0.02
Ask Price 0.021
News -
Day High

Low
0.013

52 Week Range

High
0.70

Day Low
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Propanc Biopharma Inc (QB) PPCB OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.02 09:23:44
Open Price Low Price High Price Close Price Prev Close
0.02
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.02 USD

Period:

Draw Mode:

Propanc Biopharma Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 332.02k 16.60M 11.58M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
13.43k $ - - - -

more financials information »

Propanc Biopharma (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PPCB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.020.0240.01860.0201599543,2550.000.0%
1 Month0.03150.0350.0130.0252657624,961-0.0115-36.51%
3 Months0.03240.050.0130.0279276594,870-0.0124-38.27%
6 Months0.090.148050.0130.0431421607,545-0.07-77.78%
1 Year0.41230.700.0130.0815585386,654-0.3923-95.15%
3 Years0.0262.570.00130.00889284,776,825-0.006-23.08%
5 Years0.0112.700.00130.02427373,982,8640.00981.82%

Propanc Biopharma (QB) Description

Propanc Biopharma, Inc. is developing a novel approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from pancreatic, ovarian and colorectal cancers. The Company's novel proenzyme therapy is based on the science that enzymes stimulate biological reactions in the body, especially enzymes secreted by the pancreas. These pancreatic enzymes could represent the body's primary defense against cancer.


Your Recent History
USOTC
PPCB
Propanc Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.